Mitochondrial Encephalomyopathies with Lactic Acidosis and Stroke Like Episodes——Clinical, Pathological and Mitochondrial DNA Analysis
Yan Chuan
Abstract
Yan Chuan
Abstract
Objective Mitochondrial disorder is one of the important factors in young stroke patients. To understand the clinical, pathological and molecular genetics features of Mitochondrial encephalomyopathies with lactic acidosis and stroke like episodes(MELAS). Methods Fifteen young stroke patients who were accordant with MELAS by biopsied skeletal muscle pathologies were analysed and related reports were reviewed. The clinical presentations, the findings of their biochemistry tests, the neuroimagings and the pathology of biopsied muscles were summarized. The hotspot mutations of mtDNA have been analyzed after PCR. For the patients without hotspot mutations, the sequential analyses of the entire mtDNA have been performed. Results All the patients have headache, stroke like episodes or seizures with the lesions in the cortex, especially in occipital and parietal lobes. The results of the MRI reveal some common features. Their biochemistry tests show the increase of blood lactic acid and the ratio of lactic acid to pyruvic acid and a slight increase of creatase. The biopsied muscles show the RRF and COX/SDH blue-dyed fibers with the observation of the accumulation of mitochondria and intra-mitochondrial inclusions by electric microscopy. Mitochondrial DNA analysis revealed that eleven patients were caused by mutations in leucine tRNA1 gene, while CO3*9469C/T, ATP8*8489A/G, CO1*6253T/C was supposed as the causative mutation of three patients, alternatively. But there was not any mtDNA mutation identified in a patient.Conclusion MELAS is one of important diseases among young stroke patients which can be diagnosed by pathological study of biopsied muscles. The leucine tRNA1 gene is the most frequent causative gene.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective Mitochondrial disorder is one of the important factors in young stroke patients. To understand the clinical, pathological and molecular genetics features of Mitochondrial encephalomyopathies with lactic acidosis and stroke like episodes(MELAS). Methods Fifteen young stroke patients who were accordant with MELAS by biopsied skeletal muscle pathologies were analysed and related reports were reviewed. The clinical presentations, the findings of their biochemistry tests, the neuroimagings and the pathology of biopsied muscles were summarized. The hotspot mutations of mtDNA have been analyzed after PCR. For the patients without hotspot mutations, the sequential analyses of the entire mtDNA have been performed. Results All the patients have headache, stroke like episodes or seizures with the lesions in the cortex, especially in occipital and parietal lobes. The results of the MRI reveal some common features. Their biochemistry tests show the increase of blood lactic acid and the ratio of lactic acid to pyruvic acid and a slight increase of creatase. The biopsied muscles show the RRF and COX/SDH blue-dyed fibers with the observation of the accumulation of mitochondria and intra-mitochondrial inclusions by electric microscopy. Mitochondrial DNA analysis revealed that eleven patients were caused by mutations in leucine tRNA1 gene, while CO3*9469C/T, ATP8*8489A/G, CO1*6253T/C was supposed as the causative mutation of three patients, alternatively. But there was not any mtDNA mutation identified in a patient.Conclusion MELAS is one of important diseases among young stroke patients which can be diagnosed by pathological study of biopsied muscles. The leucine tRNA1 gene is the most frequent causative gene.
Key concepts: Mitochondrial Encephalomyopathies, Lactic acidosis, Mitochondrial DNA, Medicine, Mitochondrial myopathy, MELAS syndrome, Pathological, Pathology